|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||10.12 - 10.70|
|52 Week Range||8.23 - 28.60|
|Beta (5Y Monthly)||1.72|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 15, 2022 - Nov 21, 2022|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.75|
Subscribe to Yahoo Finance Plus to view Fair Value for NNOX
NEVE ILAN, Israel, Sept. 08, 2022 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company," Nasdaq: NNOX), an innovative medical imaging technology company, today announces that Company management will participate in two investor conferences in the month of September 2022: LifeSci Partners HealthTech Symposium on September 20-21, 2022Ladenburg Thalmann Healthcare Conference on September 29, 2022 About LifeSci Partners HealthTech Symposium Nanox’s Chief Executive Officer, Erez Meltzer, an
Bringing one to market is even harder, as companies must navigate regulatory and commercial landscapes. Nano-X Imaging has learned these lessons the hard way. The Israeli company captured the imaginations of retail investors shortly after debuting on the public market two years ago but has encountered multiple regulatory and manufacturing setbacks.
One of the big advantages individual investors have over fund managers is that no one is looking over their shoulders for quick results. In this roundtable, three Motley Fool contributors picked healthcare stocks that they believe will be big winners for a long time. Here's why they recommend OrthoPediatrics (NASDAQ: KIDS), Compass Pathways (NASDAQ: CMPS), and Nano-X Imaging (NASDAQ: NNOX).